Parse Biosciences, a QIAGEN company and the leading provider of scalable and accessible single-cell sequencing solutions, today announced the commercial availability of Evercode (TM) Whole ...

BostonGene, developer of the leading AI foundation model for tumor and immune biology, announced results from the FEASY study ...

Analyzing a person’s gene expression requires mapping their RNA landscape to a standard reference to gain insight into the degree to which genes are “turned on” and perform functions in the body. But ...

To get more out of RNA-seq analysis, scientists at St. Jude Children's Research Hospital created ReDeconv, an algorithmic tool that accounts for transcriptome size differences to unmask those ...

Diagram of the haplotype-aware transcriptome analysis pipeline. Analyzing a person’s gene expression requires mapping their RNA landscape to a standard reference to gain insight into the degree to ...

Here, we address the barriers in integrating WGTS for cancer diagnostics and treatment selection and answer questions regarding utility in different cancer types, cost-effectiveness and affordability, ...

Precision oncology is shifting toward comprehensive transcriptome profiling to reveal fusions, splice variants, and expression changes that DNA panels miss. Yet obtaining reliable data from degraded ...

Detecting early stage breast cancer using low-depth cell-free DNA fragmentomics: A multi-center cohort study. Frequency of pan-cancer biomarkers across conserved TME subtypes.

Researchers introduce a method for analyzing RNA sequencing data genome-wide using a 'pantranscriptome,' which combines a transcriptome and a pangenome, creating a richer reference that can address ...